Effects of age on multidrug resistance protein expression and doxorubicin accumulation in cardiac and skeletal muscle. (18th October 2013)

• Record Type: Journal Article
• Authors: Gibson, Noah M.; Quinn, Colin J.; Pfannenstiel, Keith B.; Hydock, David S.; Hayward, Reid
• Is Part Of: Xenobiotica. Volume 44:Number 5(2014:May)
• Page Start: 472
• Page End: 479
• Publication Date: 2013-10-18
• Subjects: Anthracycline -- cancer treatment -- cardiotoxicity -- chromatography -- rat; Metabolism -- Periodicals; Drugs -- Physiological effect -- Periodicals; Food additives -- Periodicals; Chemicals -- Physiological effect -- Periodicals; Biochemistry -- Periodicals; Pharmaceutical Preparations -- metabolism -- Periodicals; Metabolism -- Periodicals; 574.133
• DOI: 10.3109/00498254.2013.846489
• Languages: English
• ISSNs: 0049-8254

Abstract

Abstract: 1.Doxorubicin (DOX) is a highly effective and commonly used anthracycline antibiotic used to treat cancer patients. The side effects of DOX are manifested in a more delayed manner in children and multidrug resistant proteins (MRPs) may factor into this phenomenon. MRPs are known to extrude DOX and may factor into the degree of cardiac DOX accumulation. 2.The purpose of this study was to examine age-related differences in muscle MRP expression and DOX accumulation. 3.Female Sprague–Dawley rats were randomly selected to receive a 15-mg DOX/kg body weight bolus injection (i.p.) at various ages. 4.Cardiac and extensor digitorum longus DOX accumulation was markedly increased as animals aged from 4 to 24 weeks. In contrast, no differences in soleus accumulation were observed. A significant age-related reduction in MRP-2 and MRP-7 expression was detected in cardiac and extensor digitorum longus tissues with no age differences in MRP-1 expression in any tissues analyzed. MRP-6 was not detected in any tissues. 5.These data suggest that aging is associated with increased DOX accumulation and an age-related decrease in MRP expression may be a factor.